Georgia Tech undergraduates organized and hosted a cross-campus symposium showcasing the impact and breadth of undergraduate neuroscience research.

Using artificial intelligence, the team is developing an edible vaccine that could protect birds from bird flu and reduce its spread to livestock and humans.

Prausnitz is awarded the highest honor given to a Georgia Tech professor.

Georgia Tech research shows how misaligned biotech–pharma partnerships can delay or derail drug development.

Students, faculty, and researchers from Georgia Tech and Kennesaw State University gathered on April 8 for a joint workshop.

Life’s first alphabet was likely small — but surprisingly powerful.

Engineers interested in creating artificial cells to deliver drugs to unhealthy parts of the body face a key challenge: for a cell-like system to move, change shape, or divide, it needs a way to generate force on command.

Researchers at Georgia Tech are using math, science, and artificial intelligence to better understand how people think, move, and perceive the world.

The 34th annual Suddath Symposium brought together researchers, trainees, and invited speakers from across disciplines to discuss cutting-edge efforts to translate synthetic biology advances into human health-relevant technologies.

AI and machine learning provide new tools for scientists to think about drug discovery.

A team of researchers led by Ankur Singh has been awarded up to $6 million from DTRA of the U.S. Department of Defense to accelerate the development of MCMs against deadly biological threats that endanger public health, national security, and warfighters.

Research published in Science Advances demonstrated the effectiveness of this technology in protecting high-value engineered cell lines.